Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02833623

Enrollment

310

Registered

2016-07-14

Start date

2016-10-31

Completion date

2017-01-31

Last updated

2016-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Pylori Eradication Rate

Keywords

Helicobacter Pylori eradication rate, Efficacy of Short-message-based Re-education (SMRE)

Brief summary

Helicobacter pylori (H. pylori) is a pathogen that infects more than 50% of the human population, resulting in high healthcare costs worldwide. However, H. pylori eradication rate is low nowadays and patients's compliance is one of the most important effective factors.

Interventions

BEHAVIORALShort-message-based Re-education

BEHAVIORALconventional education

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* outpatients aged 18-70 years * confirmed diagnosis of H. pylori infection by at least one of the following methods: 13C-urea breath test, histology, rapid urease test or bacterial culture * an intention of H. pylori eradication treatment and have written inform consent * ability to read short messages on the mobile phone

Exclusion criteria

* advanced chronic disease that would not allow the patient to complete the treatment or follow-up or attend visits * allergy to any of the drugs used in this study * previous Helicobacter Pylori eradication treatment * pregnancy or breastfeeding (female participants with childbearing potential were required to use medically accepted contraception for the duration of the study) * taking antibiotics or PPIs or bismuth salts within four weeks * previous gastrointestinal surgery

Design outcomes

Primary

Measure	Time frame
The difference of H. pylori eradication rate between two groups	8 months

Secondary

Measure	Time frame
Rate of non-compliance with instructions between 2 groups	8 months

Other

Measure	Time frame
The different rate of adverse events between 2 groups	8 months
The different rate of symptom remissions after Hp eradication therapy between 2 groups	8 months

Countries

China

Contacts

Primary ContactYanqing Li, MD,PhD

liyanqing@sdu.edu.cn86-531-82169236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026